SCHEMBL14392300

SCHEMBL14392300

NC(=O)c1cccc2nsnc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.53
▸ HSD17B10 Q99714 3/20 0.53
▸ MAPT P10636 3/20 0.53
▸ HIF1A Q16665 1/20 0.53
▸ PARP1 P09874 6/20 0.47
▸ ALDH1A1 P00352 5/20 0.47
▸ HPGD P15428 4/20 0.47
▸ CASP1 P29466 1/20 0.47
▸ TXNRD1 Q16881 1/20 0.46
▸ TXNRD3 Q86VQ6 1/20 0.46
▸ TXNRD2 Q9NNW7 1/20 0.46
▸ L3MBTL1 Q9Y468 3/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ HTT P42858 2/20 0.46
▸ ATM Q13315 1/20 0.46
▸ RAB9A P51151 4/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ NPC1 O15118 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ POLB P06746 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1338456 0.83 L3MBTL1 (0.61) KDM4EHSD17B10MAPTHIF1AALDH1A1
SCHEMBL1019293 0.81 HPGD (0.49) KDM4EHSD17B10MAPTHIF1AALDH1A1
SCHEMBL12956408 0.81 L3MBTL1 (0.58) KDM4EHSD17B10MAPTHIF1AALDH1A1
SCHEMBL19903081 0.79 KDM4E (0.46) KDM4EHSD17B10MAPTHIF1AALDH1A1
SCHEMBL12391731 0.77 POLB (0.51) KDM4EHSD17B10MAPTHIF1AALDH1A1
SCHEMBL10868710 0.75 ALDH1A1 (0.58) PARP1ALDH1A1
SCHEMBL3753741 0.74 POLB (0.47) KDM4EHSD17B10MAPTHIF1AALDH1A1
SCHEMBL25108756 0.73 RAB9A (0.45) KDM4EHSD17B10MAPTHIF1AALDH1A1
SCHEMBL2606619 0.72 PARP1 (0.62) KDM4EHSD17B10MAPTPARP1ALDH1A1
SCHEMBL818929 0.72 ALDH1A1 (0.70) MAPTPARP1ALDH1A1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007121920-A2 PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS NOVARTIS AG (CH) 2007-11-01 — — WO disclosed
Send feedback